Multiple Ascending Dose study for AZD 7268 in Japanese Healthy Male Volunteers - JMAD

Study identifier:D1151C00004

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Single-Centre, Randomised, Double-Blind, Placebo-controlled, Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7268 When Given in Multiple Ascending Oral Doses in Japanese Healthy Male Subjects

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD7268, Placebo

Sex

Male

Actual Enrollment

30

Study type

Interventional

Age

20 Years - 45 Years

Date

Study Start Date: 01 Apr 2010
Primary Completion Date: 01 Jul 2010
Study Completion Date: 01 Jul 2010

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Double Blind
Primary Purpose: Other

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria